In vitro Activity of Tigecycline and Molecular Characterization of Extended-Spectrum Beta-Lactamase-ProducingEscherichia coliandKlebsiella pneumoniaeIsolates from a University Hospital in South-Western Germany

Identifying Patients Harboring Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System

(2011) Mario Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prospective, Non-Interventional, Multi-Centre Trial of Tigecycline in the Treatment of Severely Ill Patients with Complicated Infections – New Insights into Clinical Results and Treatment Practice

(2011) Christian Eckmann et al.   CHEMOTHERAPY

Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring blaKPC from New York City and Toronto

(2011) L. F. Mataseje et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emerging Resistant Gram-Negative Aerobic Bacilli in Hospital-Acquired Infections

(2010) Anjali N. Kunz et al.   CHEMOTHERAPY

Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact

(2010) Jesús Oteo et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4

(2010) Gisele Peirano et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum  -lactamases in nursing homes in Belfast, UK

(2010) H. Dhanji et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway

(2009) UMAER NASEER et al.   APMIS

Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coliESBL producing isolates at a University hospital in Germany

(2009) Stephen E Mshana et al.   BMC INFECTIOUS DISEASES

Prevalence and Antimicrobial Resistance Patterns of Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolated from Blood Cultures in an Istanbul University Hospital

(2009) Fatma Koksal et al.   CHEMOTHERAPY

Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults

(2009) J. Oteo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15

(2009) Miguel Blanco et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Nationwide survey of extended-spectrum β-lactamase-producing Enterobacteriaceae in the French community setting

(2009) C. Arpin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence of carbapenem-non-susceptible extended-spectrum  -lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany

(2009) S. Grobner et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Characterization and Sequence Analysis of Extended-Spectrum- -Lactamase-Encoding Genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Isolates Collected during Tigecycline Phase 3 Clinical Trials

(2008) C. H. Jones et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bloodstream Infections Caused by Extended-Spectrum- -Lactamase- Producing Escherichia coli: Risk Factors for Inadequate Initial Antimicrobial Therapy

(2008) M. Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotic policy and prescribing strategies for therapy of extended-spectrum β-lactamase-producing Enterobacteriaceae: the role of piperacillin–tazobactam

(2008) L.R. Peterson   CLINICAL MICROBIOLOGY AND INFECTION

Susceptibility of common aerobic pathogens to tigecycline: results of a surveillance study in Germany

(2008) M. Kresken et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Comparative in vitro activity of tigecycline against enterobacteria producing two or more extended-spectrum β-lactamases

(2008) M. Fernández Vázquez et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Faecal carriage of extended-spectrum  -lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology

(2008) J. Rodriguez-Bano et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY